Viewing Study NCT05810792


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2025-12-29 @ 5:18 PM
Study NCT ID: NCT05810792
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-22
First Post: 2023-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
Sponsor: Sahlgrenska University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module